We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,948.00
Bid: 4,326.00
Ask: 5,250.00
Change: 0.00 (0.00%)
Spread: 924.00 (21.359%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,948.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Jun 2017 13:00

RNS Number : 0381J
Intertek Group PLC
23 June 2017
 

23 June 2017, London

Intertek Group plc ('Intertek' or 'the Company') announces Board additions

Intertek, the leading Total Quality Assurance provider to industries worldwide, announces the appointment of Gurnek Bains and Jean-Michel Valette as Non-Executive Directors of Intertek with effect from 1 July 2017.

Gurnek Bains, who is of Indian origin and lives in the UK, is the co-founder of YSC, a premier global business psychology consultancy. He led the business as CEO and Chairman for 25 years to a position of global preeminence, and a client base comprising over 40% of the FTSE100. He has a doctorate in psychology from Oxford University. He is also a Trustee of the School of Social Entrepreneurs.  

Upon joining the Board, Gurnek Bains will become a member of the Nomination Committee.

Jean-Michel Valette, who lives in the US, currently serves as an independent advisor in the US to select branded consumer companies and has more than 25 years experience in management, US public company corporate governance, strategic planning and finance. He is currently the Chairman of Select Comfort Corporation and the Lead Director and member of the Audit Committee of The Boston Beer Company, both US listed companies. From 2004 to 2012, he was Chairman of Peet's Coffee and Tea, Inc. He has an MBA from Harvard Business School.

Upon joining the Board, Jean-Michel Valette will become a member of the Audit Committee.

Under paragraph LR 9.6.13 R of the UK Listing Rules, the Company is not required to make any further disclosures in respect of Gurnek Bains and Jean-Michel Valette.

 Sir David Reid, Chairman said:

 "I am delighted to welcome two such high calibre individuals with diverse experience to the Intertek Board. 

Gurnek's wide-ranging experience, working with senior leaders across a wide range of industries internationally and his thought leadership on culture and leadership development, will provide a strong addition to the current skills on the Intertek Board.

Jean-Michel Valette brings strong US and global management experience especially in consumer and luxury goods companies which will broaden the international and customer knowledge on the Board. The US accounts for 33% of the Group's total revenues."

 -ends-

Contact:

For further information, please contact:

Josh Egan, Investor Relations

Telephone: +44 (0) 20 7396 3415 investor@intertek.com

Jonathon Brill, Oliver Winters, FTI Consulting

Telephone: +44 (0) 20 3727 1000 intertek@fticonsulting.com 

 

 

About Intertek

Total Quality. Assured.

Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 42,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers' operations and supply chains. Intertek Total Quality Assurance expertise, delivered consistently, with precision, pace and passion, enabling our customers to power ahead safely.

intertek.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABBGDLDUDBGRX
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.